- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04140331
Level of Accelerometer-assessed Preoperative Physical Activity and Short Term Outcome After Elective Cardiac Surgery (ACTI-CARD)
June 14, 2024 updated by: Centre Hospitalier Universitaire de Saint Etienne
Level of Accelerometer-assessed Preoperative Physical Activity and Short Term Outcome After Elective Cardiac Surgery. A Monocentric Prospective Observational Cohort Study
Short term morbidity after elective cardiac surgery remains significant.
Standard predictive models, considering simple patient demographics and clinical parameters, show limited efficiency in individual operative risk assessment.
There is growing evidence about daily physical activity as a relevant indicator of preoperative "frailty".
Although cardiopulmonary exercise testing remains a gold standard, we are looking for more simple tools in order to identify patients with poor physical condition.
Accelerometry may be an objective and reproductible method to measure physical activity at patient's home.
Study Overview
Detailed Description
The aim of this study is to compare accelerometer-assessed preoperative physical activity between two groups of patients with different postoperative length of stay following elective cardiac surgery.
In the future, accelerometry could be used to identify patients that may benefit from prehabilitation programs including exercise therapy before elective cardiac surgery.
Study Type
Observational
Enrollment (Actual)
202
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Saint-Étienne, France
- Chu Saint-Etienne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Adult subject (≥ 60 years) awaiting elective cardiac surgery will be included.
Description
Inclusion Criteria:
- Adult subject (≥ 60 years) awaiting elective cardiac surgery
- Patients affiliated or entitled to a social security scheme
- Patients who have received information about the study and have given their oral consent to participate
Exclusion Criteria:
- Pregnant woman,
- Major limitations in physical activity for orthopedic or musculoskeletal reasons
- Patients under judicial protection (curator or guardianship)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
complicated post-operative evolution
Patients with a postoperative intensive care unity length of stay ≥ 5 days after elective cardiac surgery.
They will have an accelerometer.
|
Patient will wear the accelerometer for 7 consecutive days to measure the level of physical activity.
|
|
simple post-operative evolution
Patients with a postoperative intensive care unity length of stay < 5 days after elective cardiac surgery.
They will have an accelerometer.
|
Patient will wear the accelerometer for 7 consecutive days to measure the level of physical activity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean daily preoperative walking activity (average of steps/day over a period of 7 days)
Time Frame: Day: 7
|
Measured by accelerometry.
|
Day: 7
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total energy expenditure evaluated over a 7 days (steps/day)
Time Frame: Day: 7
|
Measured by accelerometry.
|
Day: 7
|
|
Low activity time in hours per week (hours/week)
Time Frame: Day: 7
|
Measured by accelerometry.
|
Day: 7
|
|
Moderate activity time in hours per week (hours/week)
Time Frame: Day: 7
|
Measured by accelerometry.
|
Day: 7
|
|
Intense activity time in hours per week (hours/week)
Time Frame: Day: 7
|
Measured by accelerometry.
|
Day: 7
|
|
Time of very intense activity in hours per week (hours/week)
Time Frame: Day: 7
|
Measured by accelerometry.
|
Day: 7
|
|
Sleep time in hours per week (hours/week)
Time Frame: Day: 7
|
Measured by accelerometry.
|
Day: 7
|
|
Analysis of questionary Duke Activity Status Index (DASI) over a period of 7 days
Time Frame: Day: 7
|
Questionary Duke Activity Status Index (DASI) estimates the maximum volume of oxygen used in one minute (VO2 Max) as well as its effort capacity in metabolic equivalent. It contains 11 items. The higher the score indicates better functional capacity. |
Day: 7
|
|
Analysis of questionary Short Nutritional Assessment Questionnaire (SNAQ) over a period of 7 days
Time Frame: Day: 7
|
Questionary Short Nutritional Assessment Questionnaire (SNAQ) evaluates nutritional status.
The higher the score indicates an important nutritional support.
|
Day: 7
|
|
Dosage of albumin (g/L)
Time Frame: Day: 7
|
Measured by blood sample.
|
Day: 7
|
|
Dosage of prealbumin (g/L)
Time Frame: Day: 7
|
Measured by blood sample.
|
Day: 7
|
|
Preoperative strength assessed by dynamometry (Kg)
Time Frame: Day: 14
|
Measured by Hand Grip test.
|
Day: 14
|
|
Relationship between preoperative physical activity and duration of stay in intensive care
Time Frame: Months: 26
|
Correlation between preoperative physical activity and duration of stay in intensive care.
|
Months: 26
|
|
Preoperative clinical outcome and duration of stay in intensive care
Time Frame: Months: 26
|
Correlation between preoperative clinical outcome and duration of stay in intensive care.
|
Months: 26
|
|
Postoperative clinical outcome and duration of stay in intensive care
Time Frame: Months: 26
|
Correlation between postoperative clinical outcome and duration of stay in intensive care.
|
Months: 26
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jean-Charles PALAO, MD, Chu Saint-Etienne
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 9, 2020
Primary Completion (Actual)
April 2, 2024
Study Completion (Actual)
June 4, 2024
Study Registration Dates
First Submitted
October 24, 2019
First Submitted That Met QC Criteria
October 24, 2019
First Posted (Actual)
October 25, 2019
Study Record Updates
Last Update Posted (Actual)
June 18, 2024
Last Update Submitted That Met QC Criteria
June 14, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19CH049
- 2019-A00525-52 (Other Identifier: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Diseases
-
Baker Heart and Diabetes InstitutePrincess Alexandra Hospital, Brisbane, Australia; Royal Perth Hospital; Alice... and other collaboratorsRecruitingHeart Failure | Valve Heart DiseaseAustralia
-
Medical University of ViennaUnknownHeart Diseases | Heart Failure | Valvular Heart DiseaseAustria
-
Nantes University HospitalDirectorate of Health Care SupplyRecruitingHeart Diseases | Heart Failure | Heart Valve DiseasesFrance
-
Centre Chirurgical Marie LannelongueActive, not recruitingValvular Heart Disease | Valve Disease, Heart
-
National Defense Medical Center, TaiwanRecruiting
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Diseases | Heart Failure | Valvular Heart Disease | Biochemical DysfunctionGreece
-
Shanghai Zhongshan HospitalCompletedElectrocardiogram, Valvular Heart DiseaseChina, United Kingdom
-
Abiomed Inc.CompletedHeart Diseases | Acute Decompensated Heart Failure | Congestive Heart Failure | Acute Heart FailureUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
University of Maryland, BaltimoreCSL BehringTerminatedHeart Failure,Congestive | Heart Disease End StageUnited States
Clinical Trials on Accelerometer
-
University of East AngliaUnknown
-
University Hospital, LimogesActive, not recruiting
-
PepsiCo Global R&DCompletedSleep Quantity | Sleep EfficiencyUnited States
-
Mayo ClinicJR Albert FoundationCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedPhysical Activity | SurgeryUnited States
-
Swansea UniversityCompleted
-
University of Alabama at BirminghamWithdrawnCardiovascular Diseases | Exercise | Sickle Cell Disease
-
University of MinnesotaTerminatedAnesthesiaUnited States
-
Hull University Teaching Hospitals NHS TrustCompletedCritical Care | Walking | PostureUnited Kingdom
-
Mayo ClinicRecruitingDegenerative Thoracolumbar DeformityUnited States